TP53 and neoplasm: Interestingly, nutlin-3a enhanced cytotoxicity in a doxorubicin resistant p53-mutant neuroblastoma cell line by activating both E2F1 and p73, showing its potential benefit for highly aggressive chemoresistant p53-null tumours [198].